Measurement of glycated hemoglobin (HbA1c) has been the traditional method for
assessing glycemic control. However, it does not reflect intra-and interday glycemic …

Description: The American College of Physicians developed this guidance statement to
guide clinicians in selecting targets for pharmacologic treatment of type 2 diabetes. Methods …

OBJECTIVE Continuous glucose monitoring (CGM) has provided new measures of glycemic
control that link to diabetes complications. This study investigated the association between …

Type 2 diabetes mellitus (T2DM) is one of the major causes of premature morbidity and
mortality worldwide with the World Health Organization reporting that 1 in 10 adults …

Monitoring of glucose levels is essential to effective diabetes management. Over the past
100 years, there have been numerous innovations in glucose monitoring methods. The most …

Aims/Hypothesis Disparities in HbA1c levels have been observed among ethnic groups.
Most studies were performed in patients with diabetes mellitus (DM), which may interfere …

OBJECTIVE This study tested the hypothesis that intensive treatment in the Action to Control
Cardiovascular Risk in Diabetes (ACCORD) trial disproportionately produced adverse …

Description: In April 2017, the US Department of Veterans Affairs (VA) and the US
Department of Defense (DoD) approved a joint clinical practice guideline for the …

Studies that have compared HbA1c levels by race have consistently demonstrated higher
HbA1c levels in African Americans than in whites. These racial differences in HbA1c have …

OBJECTIVE Although patients with type 2 diabetes have double the risk of dementia,
potential racial/ethnic differences in dementia risk have not been explored in this population …